Results 11 to 20 of about 1,567,257 (239)

Epithelioid sarcoma associated with neurofibromatosis type I [PDF]

open access: yesArchives of Craniofacial Surgery, 2020
In general, patients with neurofibromatosis type I have a higher risk than those with other types of neurofibromatosis of developing soft-tissue sarcomas related to the nervous system. We here present a 42-year-old man with neurofibromatosis type I who developed a protruding mass over only 2 weeks.
Sung Oh Hwang   +2 more
openaire   +3 more sources

CVA with Neurofibromatosis Type I

open access: yesPediatric Neurology Briefs, 1992
A two year old developmentally delayed girl with neurofibromatosis type I and a sudden onset of left sided hemiparesis is reported from the Children’s National Medical Center and George Washington University School of Medicine, Washington, D.C.
J Gordon Millichap
doaj   +4 more sources

MEKK2 mediates aberrant ERK activation in neurofibromatosis type I

open access: yesNature Communications, 2020
Neurofibromatosis type I (NF1) is characterized by prominent skeletal abnormalities mediated in part by aberrant ERK pathway activation due to NF1 loss-of-function.
Seoyeon Bok   +12 more
doaj   +2 more sources

The Number of Surgical Interventions and Specialists Involved in the Management of Patients with Neurofibromatosis Type I: A 25-Year Analysis. [PDF]

open access: yesJ Pers Med, 2022
Objective: In this study, we aim to present a single institution’s 25-year experience of employing a comprehensive multidisciplinary team-based surgical approach for treating patients with NF-1.
Hsu CK   +7 more
europepmc   +2 more sources

Coexistence of neurofibromatosis type I, multiple sclerosis, and ischemic stroke: A case report and literature review [PDF]

open access: yesSAGE Open Medical Case Reports
Neurofibromatosis type I and multiple sclerosis, when considered separately, are associated with a higher risk of cerebrovascular accident. The coexistence of neurofibromatosis type I and multiple sclerosis may lead to a further increase in ...
Laura Perucca   +2 more
doaj   +2 more sources

Neurofibromatosis Type I and Stromal Tumor with a Multiple Digestive Localization [PDF]

open access: yesCase Reports in Surgery, 2021
Neurofibromatosis type I (NF1) is also known as von Recklinghausen disease. It is a genetic disorder that affects the growth and development of nerve cell tissue, which is characterized by a multisystem disorder and an increased risk for cancer.
Amina Chaka   +5 more
doaj   +2 more sources

Lung Cancer Associated with Neurofibromatosis Type I [PDF]

open access: yesCase Reports in Radiology, 2013
Lung cancer associated with neurofibromatosis type I is considered very rare, and only a few case reports have been described in the literature. There is some evidence that a genetic linkage between neurofibromatosis and carcinogenesis in the lung may ...
Anastasia Oikonomou   +4 more
doaj   +3 more sources

Neurofibromatosis type I: points to be considered by general pediatricians [PDF]

open access: yesClinical and Experimental Pediatrics, 2021
Neurofibromatosis type 1 (NF1), a prevalent genetic disease that is transmitted in an autosomal dominant manner, is characterized by multiple cutaneous café-au-lait spots and neurofibromas as well as various degrees of neurological, skeletal, and ...
Eungu Kang, Hee Mang Yoon, Beom Hee Lee
doaj   +2 more sources

Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I

open access: yesFrontiers in Genetics, 2018
Neurofibromatosis type I is a rare neurocutaneous syndrome resulting from loss-of-function mutations of NF1. The present study sought to determine a correlation between mutation regions on NF1 and the risk of developing optic pathway glioma (OPG) in ...
Min Xu   +10 more
doaj   +2 more sources

Neurovascular Issues in Neurofibromatosis Type I: Focus on Intracranial Stenosis [PDF]

open access: yesLife
Background/Objectives: Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by various clinical manifestations, including significant neurovascular complications.
Marialuisa Zedde, Rosario Pascarella
doaj   +2 more sources

Home - About - Disclaimer - Privacy